Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 4 percent year over year increase in its fiscal second quarter revenues on record performance in its diagnostics and life science segments.

For the three months ended March 31, the Cincinnati-based company's revenues rose to $56.5 million from $54.1 million a year ago, surpassing analysts' consensus estimate of $55.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.